Search research articles
Contact Us
Filters
Showing results (471-480 of 594) with videos related to
Page
of 60
Sort By:
Cardiovascular Research
|
January 12, 2008
Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload
Pascal J H Smeets, Birgit E J Teunissen, Peter H M Willemsen, et al.
Molecular Metabolism
|
April 7, 2020
Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment
Ben Arpad Kappel, Lorenzo De Angelis, Michael Heiser, et al.
American Journal of Hypertension
|
June 10, 2011
Association between a thyroid hormone receptor-α gene polymorphism and blood pressure but not with coronary heart disease risk
Louisa Goumidi, Karine Gauthier, Vanessa Legry, et al.
Frontiers in Endocrinology
|
September 19, 2022
High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation
Raphaël Decoin, Laura Butruille, Thomas Defrancq, et al.
Journal of Medicinal Chemistry
|
April 18, 2017
Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance
Manuel Lasalle, Vanessa Hoguet, Nathalie Hennuyer, et al.
Life Science Alliance
|
March 22, 2019
Sex-regulated gene dosage effect of PPARα on synaptic plasticity
Nathalie Pierrot, Laurence Ris, Ilie-Cosmin Stancu, et al.
BMC Medical Genomics
|
June 5, 2019
Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients
Daniel Margerie, Philippe Lefebvre, Violeta Raverdy, et al.
Atherosclerosis
|
September 28, 2018
Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population
Matthieu Wargny, Pierre-Henri Ducluzeau, Jean-Michel Petit, et al.
Obesity (Silver Spring, Md.)
|
September 9, 2015
The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation
Marie Favennec, Benjamin Hennart, Robert Caiazzo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 21, 2016
Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets
Leonardo A Moraes, Amanda J Unsworth, Sakthivel Vaiyapuri, et al.
Page
of 60
Search research articles
Search
Showing results (471-480 of 594) with videos related to
Sort By:
Page
of 60
Cardiovascular Research
|
January 12, 2008
Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload
Pascal J H Smeets, Birgit E J Teunissen, Peter H M Willemsen, et al.
Molecular Metabolism
|
April 7, 2020
Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment
Ben Arpad Kappel, Lorenzo De Angelis, Michael Heiser, et al.
American Journal of Hypertension
|
June 10, 2011
Association between a thyroid hormone receptor-α gene polymorphism and blood pressure but not with coronary heart disease risk
Louisa Goumidi, Karine Gauthier, Vanessa Legry, et al.
Frontiers in Endocrinology
|
September 19, 2022
High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation
Raphaël Decoin, Laura Butruille, Thomas Defrancq, et al.
Journal of Medicinal Chemistry
|
April 18, 2017
Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance
Manuel Lasalle, Vanessa Hoguet, Nathalie Hennuyer, et al.
Life Science Alliance
|
March 22, 2019
Sex-regulated gene dosage effect of PPARα on synaptic plasticity
Nathalie Pierrot, Laurence Ris, Ilie-Cosmin Stancu, et al.
BMC Medical Genomics
|
June 5, 2019
Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients
Daniel Margerie, Philippe Lefebvre, Violeta Raverdy, et al.
Atherosclerosis
|
September 28, 2018
Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population
Matthieu Wargny, Pierre-Henri Ducluzeau, Jean-Michel Petit, et al.
Obesity (Silver Spring, Md.)
|
September 9, 2015
The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation
Marie Favennec, Benjamin Hennart, Robert Caiazzo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 21, 2016
Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets
Leonardo A Moraes, Amanda J Unsworth, Sakthivel Vaiyapuri, et al.
Page
of 60